Louise Nott

2.9k total citations
65 papers, 456 citations indexed

About

Louise Nott is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Louise Nott has authored 65 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Louise Nott's work include Colorectal Cancer Treatments and Studies (41 papers), Genetic factors in colorectal cancer (17 papers) and Gastric Cancer Management and Outcomes (16 papers). Louise Nott is often cited by papers focused on Colorectal Cancer Treatments and Studies (41 papers), Genetic factors in colorectal cancer (17 papers) and Gastric Cancer Management and Outcomes (16 papers). Louise Nott collaborates with scholars based in Australia, Canada and United Kingdom. Louise Nott's co-authors include Jeremy Shapiro, Peter Gibbs, Desmond Yip, Rachel Wong, Jeanne Tie, Christos S. Karapetis, Timothy Price, Hui‐Li Wong, Margaret Lee and Kathryn Field and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Louise Nott

63 papers receiving 447 citations

Peers

Louise Nott
Brooke Vuong United States
L. Pareja Spain
Olumide B. Gbolahan United States
Ramzi Amri United States
Louise Nott
Citations per year, relative to Louise Nott Louise Nott (= 1×) peers Gábor Liposits

Countries citing papers authored by Louise Nott

Since Specialization
Citations

This map shows the geographic impact of Louise Nott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Nott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Nott more than expected).

Fields of papers citing papers by Louise Nott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Nott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Nott. The network helps show where Louise Nott may publish in the future.

Co-authorship network of co-authors of Louise Nott

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Nott. A scholar is included among the top collaborators of Louise Nott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Nott. Louise Nott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Hui‐Li, Rachel Wong, Jeremy Shapiro, et al.. (2025). Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.. Journal of Clinical Oncology. 43(4_suppl). 70–70. 1 indexed citations
2.
4.
Segelov, Eva, Wei Wang, Gwo Fuang Ho, et al.. (2023). LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial. Annals of Oncology. 34. S1269–S1269. 2 indexed citations
5.
Wong, Vanessa, Jeremy Shapiro, Rachel Wong, et al.. (2021). Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases. Clinical Colorectal Cancer. 20(4). e233–e239. 4 indexed citations
6.
Wong, Vanessa, Jeremy Shapiro, Rachel Wong, et al.. (2021). Outcomes of isolated distant lymph node metastases in colorectal cancer.. Journal of Clinical Oncology. 39(3_suppl). 84–84. 1 indexed citations
7.
Degeling, Koen, Hui‐Li Wong, Hendrik Koffijberg, et al.. (2020). Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data. PharmacoEconomics. 38(11). 1263–1275. 3 indexed citations
8.
Prasanna, Thiru, Rachel Wong, Timothy Price, et al.. (2020). Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. Current Problems in Cancer. 45(1). 100637–100637. 13 indexed citations
9.
Begbie, Stephen, Suzanne Kosmider, Sumitra Ananda, et al.. (2020). Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status. Clinical Colorectal Cancer. 20(1). e21–e34. 7 indexed citations
10.
Porubský, Štefan, Peter J. Jessup, Damien Kee, et al.. (2019). Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(2). 323–327. 1 indexed citations
11.
Shapiro, Jeremy, Subotheni Thavaneswaran, Craig Underhill, et al.. (2018). Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. Clinical Colorectal Cancer. 17(4). 313–319. 8 indexed citations
12.
Nott, Louise, et al.. (2018). Extraosseous Ewing sarcoma arising in a chronically lymphedematous limb. Journal of Vascular Surgery Cases and Innovative Techniques. 4(3). 210–215. 4 indexed citations
13.
Wong, Hui‐Li, Kathryn Field, Margaret Lee, et al.. (2018). Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?. Internal Medicine Journal. 49(4). 446–454. 9 indexed citations
14.
Jonker, Derek J., Louise Nott, Takayuki Yoshino, et al.. (2016). A randomized phase III study of napabucasin [BBI608] (NAPA) vs placebo (PBO) in patients (pts) with pretreated advanced colorectal cancer (ACRC): the CCTG/AGITG CO.23 trial. Annals of Oncology. 27. vi150–vi150. 13 indexed citations
16.
Parakh, Sagun, Hui‐Li Wong, Rajat Rai, et al.. (2015). Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia. Journal of Geriatric Oncology. 6(5). 387–394. 20 indexed citations
17.
Wong, Hui‐Li, Kathryn Field, Suzanne Kosmider, et al.. (2015). Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent. Clinical Colorectal Cancer. 15(3). e125–e132. 9 indexed citations
18.
Nott, Louise, et al.. (2008). Hyperammonaemic encephalopathy associated with rituximab‐containing chemotherapy. Internal Medicine Journal. 38(10). 800–803. 9 indexed citations
19.
Price, Timothy & Louise Nott. (2008). Unusual hair changes with prolonged erlotinib exposure. Internal Medicine Journal. 38(10). 807–807. 1 indexed citations
20.
Nott, Louise, et al.. (2007). Successfully improving access and accrual to oncology clinical trials. Cancer. 109(8). 1451–1453. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026